welcome to oneEDSvoice
- a positively charged Ehlers Danlos Syndrome community.- join today!
- login
Allele-specific siRNA Knockdown as a Personalized Treatment Strategy for Vascular Ehlers-Danlos Syndrome in Human Fibroblasts
source: The FASEB Journal
year: 2012
authors: Müller GA, Hansen U, Xu Z, Griswold B, Talan MI, McDonnell NB, Briest W
summary/abstract:The vascular type of the Ehlers-Danlos syndrome (vEDS) is caused by dominant-negative mutations in the procollagen type III (COL3A1) gene. Patients with this autosomal dominant disorder have a shortened life expectancy due to complications from ruptured vessels or hollow organs. We tested the effectiveness of allele-specific RNA interference (RNAi) to reduce the mutated phenotype in fibroblasts. Small-interfering RNAs (siRNAs) discriminating between wild-type and mutant COL3A1 allele were identified by a luciferase reporter gene assay and in primary fibroblasts from a normal donor and a patient with vEDS. The best discriminative siRNA with the mutation at position 10 resulted in >90% silencing of the mutant allele without affecting the wild-type allele. Transmission and immunogold electron microscopy of extracted extracellular matrices from untreated fibroblasts of the patient with vEDS revealed structurally abnormal fibrils. After siRNA treatment, collagen fibrils became similar to fibrils from fibroblasts of normal and COL3A1 haploinsufficient donors. In addition, it was shown that expression of mutated COL3A1 activates the unfolded protein response and that reduction of the amount of mutated protein by siRNA reduces cellular stress. Taken together, the results provide evidence that allele-specific siRNAs are able to reduce negative effects of mutated COL3A1 proteins. Thus, the application of allele-specific RNAi may be a promising direction for future personalized therapies to reduce the severity of vEDS.
organization: National Institute on AgingDOI: 10.1096/fj.11-182162
read more full text source
expertly curated content related to this topic
-
Ehlers-Danlos syndrome has Varied Molecular MechanismsEhlers-Danlos syndrome (EDS) is a group ...
-
Carotid Stiffness Change Over the Cardiac Cycle by Ultrafast Ultrasound Imaging in Healthy Volunteers and Vascular E...OBJECTIVES: Arterial stiffness is relat...
-
Pradeep Chopra, MD, MHCMPradeep Chopra, MD, MHCM is a Pain Medic...
-
Alan Pocinki, MD, PLLCDr. Pocinki is a general internist quali...
-
A Guide to Living with Ehlers-Danlos Syndrome (Hypermobility Type): Bending without Breaking (2nd edition)Covering everything from recognising sym...
-
Jeannie Di Bon, MA, PMA-CPTJeannie Di Bon is a Pilates and rehabili...
-
Acer Therapeutics Obtains Exclusive License to Celiprolol Pivotal Clinical Data from AP-HP“We have studied celiprolol for nearly...